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OBJECTIVES: To compare perioperative morbidity and
1-year outcomes of older and younger women undergoing
surgery for pelvic organ prolapse (POP).
DESIGN: Prospective ancillary analysis.
SETTING: Academic medical centers in National Insti-
tutes of Health, National Institute of Child Health and
Human Development Colpopexy and Urinary Reduction
Study.
PARTICIPANTS: Women with POP and no symptoms of
stress incontinence.
INTERVENTION: Abdominal sacrocolpopexy with ran-
domization to receive Burch colposuspension for treatment
of possible occult incontinence or not.
MEASUREMENTS: Perioperative complications and Pel-
vic Organ Prolapse Quantification and quality-of-life
(QOL) questionnaires (Pelvic Floor Distress Inventory, Pel-
vic Floor Impact Questionnaire, and Medical Outcomes
Study Short-Form Health Survey (SF-36) preoperatively,
immediately postoperatively, and 6 weeks and 3 and 12
months postoperatively).
RESULTS: Three hundred twenty-two women aged 31 to
82 (21% aged 70), 93% white. Older women had higher
baseline comorbidity (Po.001) and more severe POP
(P 5.003). Controlling for prolapse stage and whether
Burch was performed, there were no age differences in
complication rates. Older women had longer hospital stays
(3.1  1.0 vs 2.7  1.5 days, P 5.02) and higher prevalence
of incontinence at 6 weeks (54.7% vs 37.2%, P 5.005). At
3 and 12 months, there were no differences in self-reported
incontinence, stress testing for incontinence, or prolapse
stage. Improvements from baseline were significant on all
QOL measures but with no age differences.
CONCLUSION: Outcomes of prolapse surgery were com-
parable between older and younger women except that
older women had slightly longer hospital stays. J Am
Geriatr Soc 55:857–863, 2007.
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Pelvic floor disorders, including urinary incontinence,fecal incontinence, and pelvic organ prolapse (POP),
increase in prevalence with age.1 As a result of increase
in overall life expectancy, it is estimated that the number of
women aged 85 and older will double to more than 6 mil-
lion by 2030.2 It is estimated that these demographic
changes will cause the demand for pelvic floor medical ser-
vices to rise at twice the rate of growth of the total popu-
lation over the next 3 decades. Surgery, one of the most
effective treatment modalities for POP, can be associated
with significant complications, especially in older people.
Before patients can be adequately counseled about surgical
therapy, accurate age-specific data for efficacy and surgical
morbidity are needed.
Despite the pressing need for surgical outcomes data in
older patients, there is a relative paucity of such informa-
tion in the literature.3 In fact, older patients are often spe-
cifically excluded from clinical trials. One study reported
that one-third of original research papers in major medical
journals excluded elderly patients without justification.4
The data that exist regarding surgical outcomes in older
patients are somewhat mixed.
One study using data from the Nationwide Inpatient
Sample of 264,340 patients reported that older women had
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a higher risk of morbidity and mortality after urogyneco-
logical surgery.5 Similarly, in a retrospective review of 226
women undergoing surgery for incontinence at a large re-
ferral center, women aged 70 and older had a higher risk of
complications than those younger than 70.6 Conversely, a
retrospective chart review of 267 patients aged 75 and older
who underwent urogynecological surgery found a low
overall perioperative morbidity rate, although preexisting
cardiovascular disease increased the incidence of periopera-
tive complications.7 A study of 128 patients aged 80 and
older who had surgery for POP concluded that the operative
correction of POP had acceptable morbidity and a high
satisfaction rate.8
The purpose of this article is to compare perioperative
morbidity and surgical and quality of life (QOL) outcomes
at 6 weeks and 3 and 12 months in women aged 70 and
older with those younger than 70 undergoing abdominal
surgery for POP.
METHODS
This was a prospective ancillary analysis of the Colpopexy
and Urinary Reduction (CARE) Study. The study was per-
formed through the Pelvic Floor Disorders Network, a co-
operative network sponsored by the National Institute of
Child Health and Human Development. The methods and
primary outcome of CARE have been reported previous-
ly.9,10 Briefly, women with Stage II, III, or IV prolapse11
undergoing an abdominal sacrocolpopexy with no subjec-
tive evidence of urinary stress incontinence and sufficient
urethral mobility for a Burch urethropexy were invited to
participate in the study. The abdominal sacrocolpopexy
was performed through a laparotomy incision, a laparo-
scopic approach was not allowed in this protocol. All
women provided written informed consent to participate,
and eligible women were enrolled between March 2002 and
February 2005.
On the day of surgery, study participants undergoing a
sacrocolpopexy were randomized in the operating room to
have or not have a concomitant Burch colposuspension
procedure. Study participants and the research staff who
performed the follow-up assessments were blinded to the
treatment assignments for a minimum of 3 months and up
to 3 years. For the outcome variables analyzed in this paper,
the CARE population was dichotomized into women aged
70 and older and those younger than 70.
Objective assessments of POP and incontinence and
symptom-specific and general QOL questionnaires were
collected preoperatively and postoperatively at 6 weeks and
3 and 12 months. Objective assessment of prolapse was
performed using the Pelvic Organ Prolapse Quantification
Examination (POP-Q).11 At baseline, a research nurse as-
sessed preoperative urodynamics according to a study pro-
tocol with prolapse unreduced and then with prolapse
reduced. Postoperatively, stress incontinence was measured
objectively at 3 months using a standardized stress test at
300 ml or maximum capacity (whichever was less), in the
sitting and then the standing position, using Valsalva or
cough as the stress maneuver.
Women completed QOL questionnaires by telephone
survey conducted by the Quality of Life Interviewing Center
at the University of Michigan. Condition-specific QOL
instruments included the Pelvic Floor Distress Inventory
(PFDI) and Pelvic Floor Impact Questionnaire (PFIQ)
for the assessment of pelvic symptoms and their effect
on QOL.12 The three subscales of the PFDI were analyzed
separately: the Urinary Distress Inventory (28 items),
the Colorectal-Anal Distress Inventory (17 items), and
the Pelvic Organ Prolapse Distress Inventory (16 items).
The three subscales of the PFIQ were also analyzed
separately: the Incontinence Impact Questionnaire
(31 items), the Colorectal-Anal Impact Questionnaire (31
items), and the Pelvic Organ Prolapse Impact Questionnaire
(31 items).
General QOL was assessed using the 36-item Medical
Outcomes Study Short-Form Health Survey (SF-36).13 The
SF-36 has two summary indexes, the Mental Component
Summary (MCS) and the Physical Component Summary
(PCS), which are derived from the weighted averages of the
individual domain scores.14 Sexual function was measured
using the Pelvic Organ Prolapse/Urinary Incontinence Sex-
ual Function Questionnaire.15 For all QOL measures, the
median value of the subscale at baseline was calculated, as
well as the mean change from baseline at each follow-up
time point.
A comorbidity index, the Cumulative Illness Rating
Scale (CIRS)16 was used to quantitate the burden of chronic
illness. Serious adverse events, defined as untoward medical
occurrences that were life threatening or fatal or required
prolonged hospitalization or readmission for the index sur-
gery, any condition that resulted in persistent or clinically
significant disability, or any other important medical con-
dition that occurred in the immediate intra- or post-
operative and short-term (6 weeks, 3 and 12 months)
postoperative periods were recorded. A committee of three
investigators reviewed serious adverse events and used con-
sensus to group them by the affected organ system or as
febrile illnesses, wound complications, or the need for a
blood transfusion.
Demographic data collected at baseline included age,
race, marital status, level of education, employment status,
and insurance type. Baseline variables collected from past
medical history included mode of delivery, use of hormone
therapy, smoking status, previous treatments for urinary
incontinence and POP, previous hysterectomy, and medical
comorbidities (diabetes mellitus, coronary-vascular disease,
and lung disease).
Data collected intraoperatively included whether
a Burch procedure was performed and the length of the
surgery. Immediate postoperative data collection included
the length of hospital stay, blood transfusion (including
intraoperative), wound complications, and febrile compli-
cations. In addition, any organ damage or cardiovascular,
pulmonary, gastrointestinal, or neurological serious adverse
events were noted. The need for an indwelling urinary
catheter or performance of clean intermittent self-
catheterization and the number of days required for each
were included in the postoperative outcomes. Leakage of
urine postoperatively was defined as answering ‘‘yes’’ to any
of the three questions on the PFDI stress incontinence sub-
scale or stress incontinence observed on the bladder fill
stress test. Also, a general self-report question ascertaining
any urine leakage was asked at 6 weeks and 3 and 12
months postoperatively.
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Analysis
At baseline, the two groups were compared using a two-
sample t test for continuous measures or the Fisher exact
test or chi-square test for discrete variables. For outcome
variables, a general linear model was fit to the continuous
measures; age (70 vs o70) was included as an indicator
variable, and the models included as covariates the baseline
stage of POP and whether a Burch procedure was per-
formed (i.e., all P-values for outcome measures were ad-
justed for POP stage and performance of Burch procedure).
Because PFDI and PFIQ scores were not normally distrib-
uted, analyses were performed after a square root trans-
formation. When the outcome measure was discrete
(dichotomous), the Mantel-Haenszel statistic (a chi-square
statistic) was computed after adjustment for POP and per-
formance of the Burch procedure.
Although planned prospectively, this comparison was
not a primary aim of the CARE study. The following cal-
culations of power indicate the underlying differences be-
tween groups that can be tested with 80% power; they were
not used to determine the sample size. With the sample size
available for this analysis (255 women o70; 67 women
70), there was 80% power to differentiate between pro-
portions of 0.05 and 0.17, between 0.10 and 0.25, between
0.20 and 0.38, and between 0.40 and 0.60 when testing at a
5% level of significance. Also, when the dependent measure
is continuous, there is 80% power to identify a change of
0.4 standard deviations (an effect size of 0.4) when com-
paring the two groups at a 5% level of significance. Results
are presented as mean  standard deviation or n (%), and
P-values without a correction for the number of tests per-
formed.
RESULTS
Three hundred twenty-two women, ranging in age from 31
to 82, were enrolled. Twenty-one percent of participants
were aged 70 and older, and 93% were white. Table 1 dis-
plays baseline characteristics for both groups. More older
than younger women had had prior hysterectomy and pre-
vious prolapse surgery. Older women had higher baseline
comorbidity based on CIRS score and were more likely to





n 5 67 P-value
Age
Mean  SD 57.9  8.5 74.5  3.1
Median (range) 59 (31–69) 74 (70–82)
Race, n (%)
White/Caucasian 235 (92.2) 64 (95.5) .82
Black/African-American 15 (5.9) 2 (3.0)
Vaginal deliveries o.001
Mean  SD 2.8  1.4 3.6  1.4
Median (range) 3 (0–11) 3 (1–7)
Current smoker, n (%) 20 (7.9) 3 (4.5) .43
Estrogen replacement therapy, n (%) 99 (39.0) 29 (43.3) .58
Previous medication or drug treatment for incontinence, n (%) 14 (5.5) 4 (6.0) 1.00
Previous bladder training, pelvic muscle exercises, electrical stimulation,
or biofeedback for urinary incontinence, n (%)
19 (7.5) 9 (13.4) .14
Previous pessary treatment for incontinence, n (%) 13 (5.1) 10 (14.9) .01
Previous incontinence surgery, n (%) 16 (6.3) 6 (9.0) .42
Previous prolapse surgery, n (%) 93 (36.6) 33 (49.3) .07
Hysterectomy, n (%) 167 (80.3) 59 (93.7) .01
Diabetes mellitus, n (%) 12 (4.7) 4 (6.0) .75
Cumulative Illness Rating Scale score, mean  SD 3.7  3.0 5.1  3.1 o.001
Body mass index, median (range) 26 (20–49) 26 (19–39) .27
Pelvic Organ Prolapse Quantification Examination Stage .003
Mean  SD 3.0  0.6 3.2  0.6
Median (range) 3 (2–4) 3 (2–4)
Frequency Stage, n (%)
II 40 (15.7) 4 (6.0)
III 174 (68.2) 43 (64.2)
IV 41 (16.1) 20 (29.9)
Medical Outcomes Study Short-Form Health Survey, median (range)
Physical Component Summary score 47 (11–64) 45 (23–61) .43
Mental Component Summary score 54 (18–69) 54 (20–63) .94
P-value was computed using two-sample t test (when continuous), Fisher exact test (when dichotomous), or chi-square test.
SD 5 standard deviation.
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have Stage III or IV POP. There were no differences between
cohorts in baseline urodynamics, subscales of the PFDI or
PFIQ, or SF-36 MCS or PCS scores.
Fifty-five percent of older women and 47% of younger
women were randomized to Burch along with sacro-
colpopexy (P 5.27). Table 2 shows common perioperative
complications and utilization data for each group. There
were no deaths up to 1 year and only three withdrawals
from the study, all in women younger than 70. There were
no differences by age group in any perioperative complica-
tion rates. Length of hospital stay was longer in the older
women (3.1  1.0 vs 2.7  1.5 days, P 5.02). This differ-
ence remained significant after adjustment for baseline co-
morbidity (CIRS score) (P 5.04). Rehospitalization rates
were virtually the same in both age groups during the first 6
weeks (older 7.5% vs younger 5.9%; P 5.66 after adjusting
for baseline comorbidity). Rehospitalization rates between
6 weeks and 3 months were higher in older women but not
statistically significant (4.5% vs 1.2%, P 5.12 after adjust-
ing for baseline comorbidity). The most common reasons
for rehospitalization were related to the surgery and in-
cluded ileus and small bowel obstruction, pelvic infection,
and mesh erosion. Other reasons for rehospitalization in-
cluded chest pain, fever, hip fracture after fall, hypokale-
mia, and vitamin B12 deficiency.
At 6 weeks, more older women reported leakage of
urine (54.7% vs 37.2%, P 5.005), but at 3 months
(Table 3), there was no difference in self-report of urine
leakage, incontinence rates by stress test, or prolapse stage.
There were significant improvements from baseline on all
the QOL measures for both age groups, including symp-
tom-specific QOL measures and improvements in the PCS
and MCS scores of the SF-36, although there were no dif-
ferences in the baseline to 3-month change scores between
subjects aged 70 and older and those who were younger. At
12 months, there continued to be no differences between the
two age groups in prolapse stage, self-report of any urine
leakage, incontinence rates by stress test, or magnitude of
QOL and symptom score changes from baseline (Table 4).
DISCUSSION
Aging is associated with changes that can affect surgical
outcomes. These include physiological, functional, and
cognitive issues.17,18 As women are living longer, it is ex-
pected that there will be an increase in surgery for pelvic
floor disorders, yet little information exists regarding peri-
operative complications and outcomes of elective gyneco-
logical pelvic floor surgery, especially with an abdominal
approach, in older and younger women. This type of in-
formation can help doctors more effectively counsel all of
their patients undergoing surgery for urinary incontinence
and POP. Studies assessing the morbidity and mortality
from gynecological surgery in older woman reveal minimal
or no increase in mortality attributable to age alone but do
indicate greater morbidity related to underlying comorbid-
ities.19,20 Fewer studies compare perioperative outcomes
between groups of older and younger women.20,21





n 5 67 P-value
Wound complications, n (%)
Immediate 3 (1.2) 2 (3.1) .14
6 weeks 25 (10.1) 6 (9.4) .93
Febrile/dermatologic complications, n (%)
Immediate 27 (10.7) 8 (12.3) .58
6 weeks 28 (11.3) 9 (14.3) .27
Cardiovascular complications, n (%)
Immediate 12 (4.8) 4 (6.1) .82
6 weeks 3 (1.2) 1 (1.6) .79
Pulmonary complications, n (%)
Immediate 23 (9.1) 4 (6.1) .63
6 weeks 3 (1.2) 1 (1.6) .78
Gastrointestinal complications, n (%)
Immediate 48 (19.0) 13 (19.7) 1.00
6 weeks 33 (13.2) 11 (17.2) .37
Neurologic complications, n (%)
Immediate 2 (0.8) 0 .45
6 weeks 7 (2.8) 0 .20
Catheter at discharge, n (%) 75 (29.4) 13 (19.4) .11
Requires catheterization at 6 weeks, n (%) 3 (1.2) 0 .30
Any leakage of urine according to self-report at 6 weeks, n (%) 93 (37.2) 35 (54.7) .005
Length of stay, days, mean  standard deviation 2.7  1.0 3.1  1.5 .02
Rehospitalization, n (%)
To Week 6 15 (5.9) 5 (7.8) .50
6–12 Weeks 3 (1.2) 3 (4.5) .06
P-values were computed using a general linear model (when continuous) or the Mantel-Haenszel statistic (when discrete) adjusted according to Burch versus no
Burch and baseline Pelvic Organ Prolapse Quantification Examination.
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Overall, short-term outcomes of abdominal surgery for
significant POP were comparable between women aged 70
and older and those younger than 70. Older women had
more subjective complaints of incontinence at 6 weeks but
no difference at 3 and 12 months. The low prevalence of
postoperative complications in both groups may reflect an
inherent bias of surgeons to select patients with the likeli-
hood of undergoing major elective surgery uneventfully,
whereas the frailer women with POP may be offered non-
surgical treatments. This could be entirely appropriate, but
further study of selection criteria, particularly age as a
criterion, for successful pelvic surgery is needed. Despite





n 5 66 P-value
POP-Q stage of prolapse (0–3), median (range) 1 (0–3) 1 (0–3) .20
Leakage of any urine, n (%) 127 (51.4) 38 (57.6) .28
Leakage on cough stress test, n (%) 13 (5.4) 3 (4.8) .85
Change in Medical Outcomes Study Short-Form
Health Survey, mean  SD
Physical Component Summary score 1.7  9.4 0.7  7.6 .40
Mental Component Summary score 0.7  9.7 0.5  7.7 .72
Change in Pelvic Floor Distress Inventory component,
mean  SD
Urinary Distress Inventory  33.1  40.8  31.6  53.5 .42
Colorectal-Anal Distress Inventory  33.9  64.6  41.4  58.2 .45
Pelvic Organ Prolapse Distress Inventory  73.5  61.3  82.7  65.4 .43
Change in Pelvic Floor Impact Questionnaire component,
mean  SD
Urinary Incontinence Questionnaire  22.2  54.7  19.4  48.0 .46
Colorectal-Anal Impact Questionnaire  14.2  47.9  15.1  39.5 .90
Pelvic Organ Prolapse Impact Questionnaire  31.6  54.0  25.9  44.0 .43
Change in Pelvic Organ Prolapse/Urinary Incontinence
Sexual Function Questionnaire, mean  SD
3.1  6.3 3.4  4.7 .68
P-values were computed using a general linear model (when continuous) or the Mantel-Haenszel statistic (when discrete) adjusted according to Burch versus no
Burch and baseline Pelvic Organ Prolapse Quantification Examination (POP-Q).
SD 5 standard deviation.





n 5 64 P-value
POP-Q stage of prolapse (0–3), median (range) 1 (0–3) 1 (0–2) .86
Leakage of any urine, n (%) 107 (48.2) 30 (46.9) .94
Leakage on cough stress test, n (%) 7 (3.3) 1 (1.7) .55
Change in Medical Outcomes Study Short-Form
Health Survey, mean  SD
Physical Component Summary score 3.8  8.8 2.4  8.0 .35
Mental Component Summary score 0.6  8.8 1.1  7.9 .78
Change in Pelvic Floor Distress Inventory component,
mean  SD
Urinary Distress Inventory  35.4  38.1  34.7  55.4 .43
Colorectal-Anal Distress Inventory  35.8  58.2  38.2  61.9 .82
Pelvic Organ Prolapse Distress Inventory  74.3  58.9  78.8  73.1 .82
Change in Pelvic Floor Impact Questionnaire component,
mean  SD
Urinary Incontinence Questionnaire  28.8  47.3  25.7  49.3 .42
Colorectal-Anal Impact Questionnaire  18.6  44.6  12.9  41.3 .43
Pelvic Organ Prolapse Impact Questionnaire  36.2  55.9  23.7  41.6 .09
Change in Pelvic Organ Prolapse/Urinary Incontinence
Sexual Function Questionnaire, mean  SD
3.2  5.5 0.6  4.3 .09
P-values were computed using a general linear model (when continuous) or the Mantel-Haenszel statistic (when discrete) adjusted according to Burch versus no
Burch and baseline Pelvic Organ Prolapse Quantification Examination (POP-Q).
SD 5 standard deviation.
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this potential for bias, a strength of this study is that more
than 10 surgeons in seven academic medical centers across
the United States with potentially different individualized
approaches to patient care recruited patients into the
study. Therefore, the selection bias in this study should be
generalizable, at least for gynecologists and urologists
specializing in pelvic floor surgery in academic medical
centers.
Older women did have a slightly longer length of stay.
Length of hospital stay for surgery can have important im-
plications for cost of care. The older women in this study
were hospitalized approximately half a day longer than the
younger women. Although this longer stay may not seem
clinically important, the economic significance from a hos-
pital and insurance payer point of view may be substantial.
An analysis of Medicare data examining morbidity and
mortality of continence surgery in older women22 showed
that, in 66,478 patients with a mean and median age of 71
(range 65–100), length of stay increased linearly with age.
In this report, an analysis of comorbidities was performed
to determine whether the presence of medical problems af-
fected length of stay. The effect of the most common chron-
ic comorbidities (hypertension, diabetes mellitus, chronic
obstructive pulmonary disease, and dementia) did not sig-
nificantly affect length of stay, whereas the presence of
congestive heart failure slightly increased length of stay. In
the current study, the age-related increase in length of stay
was independent of comorbidity. Further exploration of
factors associated with length of stay after surgery should
include ascertaining the level of postdischarge supportive
care needed at home. Such studies could lead to alternative
models of transitional care that could reduce costs by
shortening length of stay, such as a home health aide for a
day or two after hospital discharge.
A strength of the study was use of multiple standard-
ized outcome measures administered by trained investiga-
tors blinded to treatment group. The multisite design of the
trial was another strength and increases overall generaliz-
ability, although the trial occurred primarily at academic
tertiary referral centers, which limits generalizability. An-
other limitation of the study was that, despite a large sample
size (N 5 322) for a surgical trial, only 67 of these women
were aged 70 and older, which limits statistical power. Be-
cause the prevalence of POP increases with age, one would
have expected more older women in the sample. It could be
that the increasing prevalence of comorbidities in older
women caused a selection bias by the surgeons, the referring
physicians, or the women themselves toward nonsurgical
POP treatment. Thus the sample of older women most
likely had fewer comorbidities at baseline than the general
population of older women with severe POP.
No geriatric-specific evaluations were collected before
or after surgery, including functional or cognitive assess-
ment parameters, although one previous study noted that
this did not affect outcome when collected preoperatively.23
Specifically, it was shown that a preoperative geriatric as-
sessment did not result in differences in physical or mental
health outcomes at 6 weeks or 6 months postoperatively as
measured using the SF-36 in older women who underwent
elective pelvic floor surgery. Patients were also not moni-
tored specifically for postoperative delirium, a highly preva-
lent postoperative occurrence in older patients.24
This study is one of a small number of studies that have
examined the effect of age on the surgical treatment of pel-
vic floor disorders. The cohort of older women had similar
outcomes to the younger cohort in terms of pelvic floor
symptoms, physical examination parameters, and QOL.
The older and younger cohorts had significantly better
symptom-specific and general QOL after this surgery, with
no significant age differences in the magnitude of this
change. The similar outcomes and low complication rates
seem to indicate that chronological age should not be an
exclusion criterion for an abdominal approach to POP sur-
gery. This is an important study considering the underrep-
resentation of older persons, and older women in particular,
in randomized clinical trials. A review of 20 randomized
clinical trials of surgery for stress incontinence3 found that
the median percentage of subjects aged 70 and older was
3.8%, which is remarkably disproportional to the number
of older women undergoing these procedures. As the popu-
lation ages and increasing numbers of older women are
undergoing treatment for POP25 and urinary stress incon-
tinence,26 it is imperative that barriers to the inclusion of
older women in research on pelvic floor disorders be over-
come.
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